The Importance of Genomics in Clinical Trials for Mixed-Race Participants

Recent U.S. Census data shows a 276% rise in the multiracial population, from 9 million in 2010 to 33.8 million in 2020. This shift emphasizes the necessity of diverse representation in clinical trials. Enhanced genomic profiling could lead to more effective, equitable healthcare for all racial and ethnic backgrounds.